20550 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters; Glycosaminoglycans, i.e. mucopolysaccharides Heparin; Heparan
mGluR receptor antagonists for use in prevention andor treatment of bone marrow lesions (BML) andor osteoporosis, cartilage loss, osteosclerosis and osteitis in a mammal
#2ANTICOAGULANT-PEPTIDE NANOGRANULES FOR THROMBOSIS-ACTUATED ANTICOAGULATION
#3PAINLESS NGF FOR FRACTURE REPAIR
#4ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES
#5COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE
#6TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#7METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)
#8GASTROINTESTINAL PROTECTANT COMPOSITION
#9BIOMIMETIC EXTRACELLULAR MATRIX NANOFIBERS ELECTROSPUN WITH CALRETICULIN
#10HEPARIN COMPOSITIONS FOR TREATMENT OF LUNG DAMAGE AND METHODS OF USE THEREOF
#11Structurally and Functionally Repaired Endothelial Glycocalyx
#12CHEMICALLY MODIFIED HEPARIN
#13NEW MEDICAL USE OF TAFOXIPARIN
#14CHEMICALLY MODIFIED HEPARIN
#15TRPV2 CHANNEL BLOCKERS AND USE THEREOF
#16METHODS AND SYSTEMS FOR INHIBITING FOREIGN-BODY RESPONSES IN DIABETIC PATIENTS
#17EFFICIENT TRANSDERMAL DELIVERY SYSTEM FOR ACIDIC GROUP-CONTAINING BIOMATERIAL
#18STING AGONIST-CONTAINING UREASE-POWERED NANOMOTOR-BASED BLADDER CANCER IMMUNOTHERAPY AGENT
#19Therapeutic Nanomaterials
#20ORAL FORMULATION BASED ON A PRE-ESTABLISHED ASSOCIATION OF SULODEXIDE AND FLAVONOIDS FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY AND PREVENTION OF COMPLICATIONS THEREOF
#21METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#22THERAPEUTIC METHODS
#23DISRUPTION OF SONIC HEDGEHOG-SURF4 INTERACTION FOR CANCER TREATMENT
#24BIOMARKER COMPOSITION FOR DIAGNOSING HEMOSTATIC DISORDERS, COMPRISING MIRNAS IN EXTRACELLULAR VESICLES
#25NEW USE
#26NEW USE
#27DIAGNOSTIC OR PREDICTOR OF RELAPSING REMITTING MULTIPLE SCLEROSIS
#28ANTICOAGULANT HEPARIN-CHONDROITIN CHIMERIC SACCHARIDE MOLECULE AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF
#29FLEXIBLE INTERCONNECTED MICROPARTICLES ARRAYS: DEVICES, METHODS, COMPOSITIONS AND APPLICATIONS
#30SYSTEMS AND METHODS TO IDENTIFY AND TREAT SUBJECTS AT RISK FOR OBSTETRICAL COMPLICATIONS
#31IMPROVED HEPARAN SULFATE AND METHODS OF MAKING THE SAME
#32GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY TO REDUCE INSTANT BLOOD MEDIATED INFLAMMATORY REACTIONS
#33SYSTEMS AND METHODS USING SULFATED GLYCOSAMINOGLYCANS (GAGs) AND GAG ANALOGS TO TREAT OR PREVENT MONKEYPOX (MPOX)
#34COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2
#35MEDICATION INFUSION COMPONENTS AND SYSTEMS
#36BIOACTIVE GRANULAR HYDROGEL SCAFFOLDS AND USE THEREOF
#37COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2
#38Sodium thiosulfate-containing pharmaceutical compositions
#39Phosphodiesterase 4 Inhibitor Decreases Thrombosis in Simulated ECMO Model
#40SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
#41HYDROGEL FORMULATION USED AS VITREOUS SUBSTITUTE AND PRODUCTION METHOD THEREOF
#42DEPLETING EGFR AND HER2 OVERCOMES RESISTANCE TO EGFR INHIBITORS IN COLORECTAL CANCER
#43METHODS OF PREVENTING A VENOUS THROMBOEMBOLIC EVENT
#44A Drug-Eluting Stent Comprising a Biocompatible Thermoplastic Polymer Lining and a Drug- Containing Coating
#45COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR
#46ANTI-C5 ANTIBODIES COMBINATIONS AND USES THEREOF
#47Polychromatic Phototherapy Device and Method
#48PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
#49METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE
#50HEPARIN FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING
#51PAINLESS NGF FOR FRACTURE REPAIR
#52COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED DISORDERS
#53METHODS, COMPOSITIONS, AND DEVICES FOR DRUG / LIVE CELL MICROARRAYS
#54MEDIUM MOLECULAR WEIGHT HEPARIN FOR USE IN THE TREATMENT OF ENDOTHELIOPATHY
#55SULFATED OLIGOSACCHARIDES HAVING ANTI-INFLAMMATORY ACTIVITY
#56RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
#57HUMAN PLURIPOTENT STEM CELL-DERIVED SECRETOME AS A BIOLOGIC FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE AND APOPTOTIC DISEASES
#58COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION
#59VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
#60INFLAMMASOME ANTIBODY COMPOSITON AND METHOD FOR TREATING NEUROLOGIC DISORDER
#61COMPOSITIONS AND METHODS TO REDUCE INFILTRATION OF PATHOGENIC AND ANTHROPOGENIC ENVIRONMENTAL FACTORS INTO THE BRAIN
#62METHODS AND COMPOSITIONS FOR TREATING A CORONAVIRUS INFECTION
#63ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
#64SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
#65Diagnostic or predictor of relapsing remitting multiple sclerosis
#66REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS
#67PLATELET DERIVATIVES FOR TREATING COAGULOPATHY
#68TREATMENT OF PAIN WITH POLYSULFATED POLYSACCHARIDES
#69SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS
#70USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
#71Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof
#72METHOD FOR IDENTIFYING AND/OR FOR OBTAINING AN ACTIVE SUBSTANCE FOR THE TREATMENT AND THERAPY OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND USE OF AN ACTIVE SUBSTANCE FOR THE TREATMENT OF THIS DISEASE
#73TISSUE-DERIVED MATRIKINE COMPOSITIONS AND METHODS THEREFOR
#74USE OF A HEPARIN COMPOSITION IN THE TREATMENT OF VIRAL LUNG DISEASES, ACUTE AND/OR CHRONIC LUNG DISEASES BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE
#75METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTION
#76COMPOSITION DERIVED FROM MAMMALIAN UMBILICAL CORD AND WHARTONS JELLY FOR USE IN THERAPEUTIC AND REGENERATIVE APPLICATIONS
#77SPRAYABLE ANTIVIRAL FORMULATION
#78CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN
#79DEUTERATED RUC-4
#80MEDICAL USE OF TAFOXIPARIN
#81HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES
#82FIBROBLAST AND TLR ACTIVATED FIBROBLAST TREATMENT OF VIRAL INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME
#83METHOD FOR TREATING COMPLEMENT MEDIATED DISORDERS CAUSED BY BETACORONAVIRUSES
#84Systems and methods to identify and treat subjects at risk for obstetrical complications
#85METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES
#86ORAL DELIVERY OF HEPARINS
#87METHODS OF MANUFACTURING A HIGH MOLECULAR WEIGHT HEPARIN COMPOUND
#88TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#89FISH SWIM BLADDER-DERIVED HEPARIN-LIKE MUCOPOLYSACCHARIDE AND METHODS OF MAKING AND USING THE SAME
#90Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia
#91MODULATION OF FACTOR 11 EXPRESSION
#92COMPOSITIONS OF EDTA HAVING ACTIVITY AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS
#93PARTIALLY DESULFATED HEPARIN FOR TREATING CORONAVIRAL INFECTIONS
#94CANCER THERAPEUTIC COMPOSITIONS AND METHODS TARGETING DNASE1L3
#95METHODS FOR MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG
#96Method of synergetic minimization of negative impact caused by flights on human health
#97COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE
#98COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION
#99POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS
#100COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR OTHER NEGATIVELY CHARGED MOLECULES
#101COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2
#102ANTICOAGULANT COMPOUNDS AND METHODS AND DEVICES FOR THEIR USE
#103Sodium thiosulfate-containing pharmaceutical compositions
#104INHIBITION OF SARS-COV-2 INFECTION THROUGH SYNDECANS
#105HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19 PATIENTS
#106DIAGNOSIS AND TREATMENT OF COVID-19
#107Delivery device and formulation
#108TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIA
#109Method for obtaining low molecular weight heparins and low molecular weight heparins obtained therefrom
#110ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY
#111HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS
#112MEDICATION INFUSION COMPONENTS AND SYSTEMS
#113MEDICAL USE OF ICARITIN
#114HEPARANASE INHIBITORS FOR TREATMENT OF DIABETES
#115Methods For Treating Coronavirus Disease
#116NANOPARTICLES FOR USE IN THE TREATMENT AND DIAGNOSIS OF CNS DISORDERS
#117REPAIR AND/OR RECONSTITUTION OF INVERTEBRAL DISCS
#118METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE
#119COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#120Methods for synthesizing anticoagulant polysaccharides
#121Medication infusion components and systems
#122Heparanase Inhibitor as Anti-Viral and Immunomodulatory Therapy
#123Methods of manufacturing a high molecular weight heparin compound
#124Methods of generating, repairing and/or maintaining connective tissue in vivo
#125TREATMENT OF MYELOSUPPRESSION
#126EXTERNAL PREPARATION FOR SKIN
#127Heparin and heparan sulphate oligosaccharides
#128PHARMACEUTICAL COMPOSITION
#129IMMUNOACTIVE MICROPARTICLES AND USES THEREOF
#130HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#131HEPARIN AND HEPARAN SULFATE FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING
#132USE OF HEPARIN TO PROMOTE TYPE 1 INTERFERON SIGNALING
#133ANTITHROMBOTIC COATING COMPOSITION AND ANTITHROMBOTIC COATING METHOD USING SAME
#134Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory Drug
#135Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory Drug
#136Anti-C5 antibody combinations and uses thereof
#137MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL INSTILLATION, PREPARATION AND USE THEREOF
#138ORONASAL CBD FORMULATIONS AND USES THEREOF
#139HEPARAN SULFATE (HS) OLIGOSACCHARIDES EFFECT IN LIVER ISCHEMIA REPERFUSION INJURY
#140Targeted apheresis to treat preeclampsia
#141COMPLEMENT INHIBITION FOR IMPROVED NERVE REGENERATION
#142MEDICAL DEVICE AND METHOD FOR PRODUCING MEDICAL DEVICE
#143PROCESSES AND AGENTS FOR GLAUCOMA
#144SPECIAL HEPARINOID COMPOSITION, WITH REPAIR, PROPHYLACTIC AND ANTI-INFLAMMATORY EFFECTS, APPLIED TO THE LUNGS
#145Manifold With Biological Actives For Negative-Pressure Therapy
#146NASAL SPRAY FOR PREVENTING INFLUENZA BASED ON RED PEPPER EXTRACT AND HEPARIN AND PREPARATION METHOD THEREOF
#147PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST AN AGENT SELECTED FROM MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYCLIC ACID AND PARACETAMOL
#148METHODS FOR MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG
#149Methods and compositions for treating virus-associated inflammation
#150PAINLESS NGF FOR FRACTURE REPAIR
#151Systems for Delivery of Therapies by Trans-maxillary Access
#152Therapeutic nanomaterials
#153Antithrombin-III Treatment of Traumatic Brain Injury
#154METHODS FOR TREATING INTRACRANIAL HEMORRHAGE AND ASSESSING EFFICACY
#155COMPOSITIONS AND METHODS FOR TREATMENT OF A CORONAVIRUS DISEASE (COVID-19) INFECTION
#156SAFE BOVINE HEPARIN, PREPARATION METHOD, AND APPLICATION
#157NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF
#158METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
#159Method for modulating endothelial glycocalyx structure
#160INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#161Sodium thiosulfate-containing pharmaceutical compositions
#162MEDICAL BASE MATERIAL FOR INDWELLING CARDIOVASCULAR DEVICE
#163NOVEL DRUG DELIVERY CONJUGATED MOIETY FOR ORAL ADMINISTRATION OF DRUG UNSUITABLE FOR ORAL ADMINISTRATION AND PREPARATION METHOD THEREOF
#164TREATMENT OF ACUTE MYELOID LEUKEMIA WITH HYPOMETHYLATING AGENTS AND 2-O, 3-O DESULFATED HEPARINOIDS
#165COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#166Anticoagulant compounds and methods and devices for their use
#167Medication infusion components and systems
#168Compositions for Broad Spectrum Topical Antimicrobials
#169Methods for synthesizing anticoagulant polysaccharides
#170Methods and compositions for treating and preventing viral infection
#171COMPOSITION AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#172ORONASAL CBD FORMULATIONS AND USES THEREOF
#173COMPOSITION THAT FORMS LIQUID CRYSTALLINE PARTICLES
#174BIOLOGICALLY ACTIVE COMBINATORIAL POLYSACCHARIDE DERIVATIVES
#175Deuterated RUC-4
#176Shear-thinning therapeutic composition, and related methods
#177DERIVATIVES OF N-DESULFATED GLYCOSAMINOGLYCANS AND USE AS DRUGS
#178Treatment of pain with polysulfated polysaccharides
#179HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS
#180METHODS FOR MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG
#181TREATMENT AND DIAGNOSIS OF OCULAR SURFACE DISORDERS
#182METHOD FOR REDUCING THE OCCURRENCE OF THROMBOSIS OR THROMBOEMBOLISM
#183Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues
#184Polychromatic phototherapy device and method
#185Complex coacervate for controlled release and related methods
#186Method for treatment of a viral-mediated infectious disease
#187COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME RELATED DISEASES OR CONDITIONS
#188TARGETED NANOPARTICLES
#189Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
#190METHOD FOR PRODUCING SUSTAINED-RELEASE DRUG, AND SUSTAINED-RELEASE DRUG
#191Methods, compositions, and devices for making sustained biodegradable implants in tissue
#192COMPOSITION CONTAINING BECLOMETHASONE FOR THE PREVENTION AND THE TREATMENT OF BACTERIAL PROSTATITIS AND VAGINITIS
#193Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
#194Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
#195Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
#196ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
#197Method of treating, reducing, or alleviating a medical condition in a patient
#198Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy
#199LD Heparin for the treatment and secondary prevention of ischemic stroke
#200DRUG-LOADED TISSUE ADHESIVE FILM AND PREPARATION METHOD THEREFOR
#201Method of synergetic minimization of negative impact caused by flights on human health
#202METHODS FOR DIAGNOSING, PROGNOSING AND MONITORING TREATMENT FOR THROMBOSIS IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
#203THERAPEUTIC HYDROGEL MATERIAL AND METHODS OF USING THE SAME
#204COMBINATION WEARABLE AND STATIONARY DIALYSIS SYSTEMS
#205Heparanase inhibitors for treatment of diabetes
#206Sulfated oligosaccharides having anti-inflammatory activity
#207Modulation of factor 11 expression
#208CARRIER STATUS OF ANNEXIN A5 M2 HAPLOTYPE AND OBSTETRIC RISKS
#209Heparin and heparan sulphate oligosaccharides
#210Short-acting heparin-based anticoagulant compounds and methods
#211Compositions, methods and devices for forming implants from injected liquids
#212Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#213Vasoprotective and cardioprotective antidiabetic therapy
#214Methods and Compositions for the Diagnosis and Treatment of Kawasaki Disease
#215Enzymatic preparation of increased anticoagulant bovine sourced heparin
#216System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
#217Implantable medical device having a negatively-charged and antimicrobial surface
#218Heparin composition for treating ischemia
#219Indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells
#220COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD
#221Derivatives of N-desulfated glycosaminoglycans and use as drugs
#222HYALURONIC ACID SYNTHESIS PROMOTER, METHOD FOR PROMOTING HYALURONIC ACID SYNTHESIS, AND CELL EVALUATION METHOD
#223Protein biomaterials and biocoacervates and methods of making and using thereof
#224THROMBIN-RESPONSIVE HYDROGELS AND DEVICES FOR AUTO-ANTICOAGULANT REGULATION
#225METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#226Method of Treating Parkinson's Disease
#227Oral dissolving films containing microencapsulated vaccines and methods of making same
#228Compositions and methods to treat disease
#229HEPARIN-BASED BLOOD SAMPLER WITHOUT PLATELET ACTIVATION
#230Compositions of Fibroblast Growth Factor LIgands and Methods of Treating Patients Undergoing Ischemia-Reperfusion Therapy
#231Methods and compositions for the prevention and treatment of disease
#232ADHESION LAYER BONDED TO AN ACTIVATED SURFACE
#233Unit aerosol doses for anticoagulation
#234Methods for treating lung inflammation with an anti-ASC antibody
#235Methods of treating inflammatory skin disorders
#236METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
#237ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
#238INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#239Sodium thiosulfate-containing pharmaceutical compositions
#240Diagnostic or predictor of relapsing remitting multiple sclerosis
#241Method of treating, reducing, or alleviating a medical condition in a patient
#242Treatment of immunological disease using berberine nanoparticles
#243METHODS AND COMPOSITIONS FOR MOBILIZING STEM CELLS
#244Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit
#245Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
#246Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof
#247TREATMENT OF CANCERS AND HEMATOPOIETIC STEM CELL DISORDERS PRIVILEGED BY CXCL12-CXCR4 INTERACTION
#248Method of making an in situ sustained biodegradable drug delivery implant by filling an artificial tissue cavity
#249Derivatives of N-desulfated glycosaminoglycans and use as drugs
#250Antithrombotic medical material using nickel titanium alloy
#251Method and apparatus for adding an anticoagulant to the blood of a patient
#252Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia
#253THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA
#254DETECTION OF HIGH RISK ARTERIAL THROMBOEMBOLIC DISEASES BY MARKERS OF COAGULATION AND HEMOSTATIC ACTIVATION
#255METHODS AND SYSTEMS FOR INHIBITING FOREIGN-BODY RESPONSES IN DIABETIC PATIENTS
#256Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#257COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR
#258Enzymatic preparation of increased anticoagulant bovine sourced heparin
#259Methods for forming implants from injected thermoreversible gels
#260Chitosan magnetic particle drug carrier, drug structure, and method of making
#261Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
#262HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#263COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND LENALIDOMIDE
#264RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
#265Treatment of myelosuppression
#266IN VITRO HEPARIN AND HEPARAN SULFATE COMPOSITIONS AND METHODS OF MAKING AND USING
#267COMPOSITION FOR WOUND HEALING
#268Functionalized Scaffold To Promote Meniscus Repair
#269Modulation of Factor 11 expression
#270Blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings
#271Medium molecular weight heparin
#272METHODS FOR MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG
#273NOVEL INTERSTITIAL THERAPY FOR IMMEDIATE SYMPTOM RELIEF AND CHRONIC THERAPY IN INTERSTITIAL CYSTITIS
#274Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
#275METHOD AND KIT FOR MYOCARDIAL REPERFUSION, AND METHOD FOR ATTENUATING OR REDUCING MYOCARDIAL REPERFUSION INJURY
#276Systems and methods to identify and treat subjects at risk for obstetrical complications
#277Compounds for treatment of lipoprotein metabolism disorders
#278Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#279Methods of applying active components
#280Heparin and Statin Combinations for Preventing Metastatic Cancer
#281Delivery device and formulation
#282Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders
#283Transduction
#284Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#285Shear-thinning therapeutic composition, and related methods
#286Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts
#287Anti-C5 antibody combinations and uses thereof
#288Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
#289Topical preparation for skin tissue protection and reparation
#290REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#291Sodium thiosulfate-containing pharmaceutical compositions
#292HEPARAN SULPHATE
#293Protein biomaterials and biocoacervates and methods of making and using thereof
#294Targeted nanoparticles
#295Sodium thiosulfate-containing pharmaceutical compositions
#296Method for olfactory improvement with saccharide
#297Activated polyoxazolines and conjugates and compositions comprising the same
#298Coacervate micro and/or nano droplets and hydrogels
#299Method and apparatus for microneedle transdermal delivery
#300Peptide-based methods for treating neurological injury